
Mr. Speaker, many concerned Americans are fed up with a Washington system that doesn't solve the underlying problems facing the nation, including the ongoing debt crisis. This ongoing debt debate represents not just a crisis, but a…
On the public record
Every politician on the site, every statement on file. Search, filter, and read the public record.
17,200+·quotes on file

Mr. Speaker, many concerned Americans are fed up with a Washington system that doesn't solve the underlying problems facing the nation, including the ongoing debt crisis. This ongoing debt debate represents not just a crisis, but a…

Mr. Speaker, since our Republican colleagues assumed the majority in January, we have swung from one artificially created crisis to the next. In the spring, we barely dodged a government shutdown. Now we face an unprecedented and…

If we don't have measurement tools to determine whether a fee system produces a better outcome, then I'm not sure why we would sign off on it as policymakers.

the review of the 510(k) products. It's become particularly burdensome, causing product approval delays and the frustration for the manufacturers, providers, and obviously the patients.

I'm very concerned about the strength of the U.S. industry, the ability of American companies to deliver the products, drugs and devices that the American people need.

But is it the agency's policy to ignore the statute in the law?

It's a disturbing day when I think that the argument is, provide us more money and we'll do a better job.

But in North Carolina, we have about 19,000 biopharmaceutical jobs in our State, and it is such an important part of our economy, and I want to make sure we do all we can to invest in this sector and protect and attract even more jobs.

I'm concerned that there's a proposal to regulate laboratory diagnostic tests as medical devices, and they're already regulated under CLIA.

Is it alarming to you that American companies would choose not to seek American approval for breakthroughs that they have?

This committee, as well as one in the House, has the policy responsibilities for the Food and Drug Administration.

I would just urge you to help improve upon the efforts to provide frequent, transparent communication with the companies.

Tell me why we should reauthorize user fees for pharmaceuticals and devices when, in the case of devices, the length of time has gone up since we instituted user fees?

DOD plans to apply approximately $6.2 billion towards the design, development, procurement, test and evaluation, and deployment of the systems identified in question #4 over fiscal years 2012 to 2016.

Modernizing DOD's business systems is a key aspect of our overall effort to achieve auditability.

DOD has applied approximately $7.2 billion towards the design, development, procurement, test and evaluation, and deployment of these systems since their inception.

Mr. Speaker, is President Obama really pushing to raise taxes while unemployment hovers around 9 percent just to get an increase in the debt limit? Republicans beg to disagree. Increasing taxes on American job creators and families will…

Mr. Speaker, our record debt of $14.3 trillion is growing, and it poses a direct threat to our national security, our economy, and our children's future. The American people deserve real leadership right now, not politics as usual. The…